Leigh MacMillan Archive — Page 79 of 85
-
August 30, 2012
Targeting new pathways to ease pain
The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics. -
August 28, 2012
Clues to retinal cell degeneration
A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells. -
August 23, 2012
VU, Lipscomb partner on dual degree program
A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists. -
August 14, 2012
Flu Tool guides patient decision-making
Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources. -
August 9, 2012
New therapeutic target for cold, flu viruses identified
Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells. -
August 9, 2012
Team creates new view of body’s infection response
A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.